These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 29787333)

  • 1. Investigator Disclosure and Advanced Cancer Patient Understanding of Informed Consent and Prognosis in Phase I Clinical Trials.
    Hlubocky FJ; Kass NE; Roter D; Larson S; Wroblewski KE; Sugarman J; Daugherty CK
    J Oncol Pract; 2018 Jun; 14(6):e357-e367. PubMed ID: 29787333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do Patients With Advanced Cancer Have the Ability to Make Informed Decisions for Participation in Phase I Clinical Trials?
    Hlubocky FJ; Sachs GA; Larson ER; Nimeiri HS; Cella D; Wroblewski KE; Ratain MJ; Peppercorn JM; Daugherty CK
    J Clin Oncol; 2018 Aug; 36(24):2483-2491. PubMed ID: 29985748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perceptions of cancer patients and their physicians involved in phase I trials.
    Daugherty C; Ratain MJ; Grochowski E; Stocking C; Kodish E; Mick R; Siegler M
    J Clin Oncol; 1995 May; 13(5):1062-72. PubMed ID: 7738612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of cohort-specific consent and patient control in phase I cancer trials.
    Daugherty CK; Ratain MJ; Minami H; Banik DM; Vogelzang NJ; Stadler WM; Siegler M
    J Clin Oncol; 1998 Jul; 16(7):2305-12. PubMed ID: 9667244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What advanced cancer patients with limited treatment options know about clinical research: a qualitative study.
    Garrett SB; Koenig CJ; Trupin L; Hlubocky FJ; Daugherty CK; Reinert A; Munster P; Dohan D
    Support Care Cancer; 2017 Oct; 25(10):3235-3242. PubMed ID: 28488050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of therapeutic research on informed consent and the ethics of clinical trials: a medical oncology perspective.
    Daugherty CK
    J Clin Oncol; 1999 May; 17(5):1601-17. PubMed ID: 10334550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase 1 oncology trials and informed consent.
    Miller FG; Joffe S
    J Med Ethics; 2013 Dec; 39(12):761-4. PubMed ID: 23161617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Informed consent: the physicians' perspective.
    Taylor KM; Kelner M
    Soc Sci Med; 1987; 24(2):135-43. PubMed ID: 3563556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the content and process of informed consent discussions for neonatal research.
    Marc-Aurele KL; Steinman SL; Ransom KM; Finer NN; Dunn LB
    J Empir Res Hum Res Ethics; 2012 Jul; 7(3):78-83. PubMed ID: 22850145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Informed consent in psychiatric research: preliminary findings from an ongoing investigation.
    Benson PR; Roth LH; Winslade WJ
    Soc Sci Med; 1985; 20(12):1331-41. PubMed ID: 2862705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Informed consent in the Childrens Cancer Group: results of preliminary research.
    Kodish ED; Pentz RD; Noll RB; Ruccione K; Buckley J; Lange BJ
    Cancer; 1998 Jun; 82(12):2467-81. PubMed ID: 9635541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Informed consent in clinical research at a general hospital in Mexico: opinions of the investigators.
    Vargas-Parada L; Kawa S; Salazar A; Mazön JJ; Flisser A
    Dev World Bioeth; 2006 Mar; 6(1):41-51. PubMed ID: 16436173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Must patients with advanced cancer choose between a Phase I trial and hospice?
    Casarett DJ; Karlawish JH; Henry MI; Hirschman KB
    Cancer; 2002 Oct; 95(7):1601-4. PubMed ID: 12237931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of informed consent in cancer clinical trials: a cross-sectional survey.
    Joffe S; Cook EF; Cleary PD; Clark JW; Weeks JC
    Lancet; 2001 Nov; 358(9295):1772-7. PubMed ID: 11734235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients' perceptions on informed consent and the quality of information disclosure in clinical trials.
    Verheggen FW; Jonkers R; Kok G
    Patient Educ Couns; 1996 Nov; 29(2):137-53. PubMed ID: 9006231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variations in Unrealistic Optimism Between Acceptors and Decliners of Early Phase Cancer Trials.
    Jansen LA; Mahadevan D; Appelbaum PS; Klein WMP; Weinstein ND; Mori M; Degnin C; Sulmasy DP
    J Empir Res Hum Res Ethics; 2017 Oct; 12(4):280-288. PubMed ID: 28728498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Informed consent for phase I studies: evaluation of quantity and quality of information provided to patients.
    Tomamichel M; Sessa C; Herzig S; de Jong J; Pagani O; Willems Y; Cavalli F
    Ann Oncol; 1995 Apr; 6(4):363-9. PubMed ID: 7619751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parents' and children's comprehension and decision in a paediatric early phase oncology trial: a prospective study.
    Béranger A; Bouazza N; de Haut de Sigy A; Foubert-Wenc AC; Davous D; Aerts I; Geoerger B; Auvrignon A; Brethon B; Leblond P; Corradini N; André N; Martinez H; Dupont JK; Doz F; Chappuy H
    Arch Dis Child; 2019 Oct; 104(10):947-952. PubMed ID: 30472665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What oncologists believe they said and what patients believe they heard: an analysis of phase I trial discussions.
    Jenkins V; Solis-Trapala I; Langridge C; Catt S; Talbot DC; Fallowfield LJ
    J Clin Oncol; 2011 Jan; 29(1):61-8. PubMed ID: 21098322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dispositional optimism and therapeutic expectations in early-phase oncology trials.
    Jansen LA; Mahadevan D; Appelbaum PS; Klein WM; Weinstein ND; Mori M; Daffé R; Sulmasy DP
    Cancer; 2016 Apr; 122(8):1238-46. PubMed ID: 26882017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.